Merdury Biopharmaceutical Corporation (6932)
Market Closed
11 Aug, 05:30
TWSE 
JPX Primary TWSE NT$
7. 09
+1.26
+21.6123%
NT$
- Market Cap
- P/E Ratio
88% Div Yield
2.73M Volume
- Eps
NT$ 5.83
Previous Close Want to track 6932 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Merdury Biopharmaceutical Corporation (6932) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.13B
Trailing P/E (ttm) -32.06
Forward P/E -
PEG ratio 0.84
Price/Sales (ttm) -
Price/Book (mrq) 9.87
Enterprise Value/Revenue -
Enterprise Value/EBITDA -37.4
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 336.33K
Average volume (90 days) 270.71K
Price summary
52-Week low 4.71
52-Week high 12.2
Beta -
50-Day moving average 5.79
200-Day moving average 7.33
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.24%
Return on equity -0.28%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0.19
Current ratio (mrq) 8.84%
Book value per share (mrq) 0.52
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
